Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
2020 · Nature Medicine · 618 citations
https://doi.org/10.1038/s41591-020-1008-z
Y
Yanming Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
336
Papers
6.3K
Citations
37
h-index
106
i10-index
Yanming Zhang is an academic researcher from Shenyang Jianzhu University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Multiple Myeloma Research and Treatments & Acute Lymphoblastic Leukemia research. The author has an h-index of 37, co-authored 286 publications.
ORCID: 0009-0006-0610-9463Papers by this author
worksBlinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
2024 · New England Journal of Medicine · 183 citations
https://doi.org/10.1056/nejmoa2312948
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
2021 · Nature Communications · 124 citations
https://doi.org/10.1038/s41467-021-22140-0
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
2018 · Nature Communications · 111 citations
https://doi.org/10.1038/s41467-018-04356-9
A recurrent novel <i>MGA–NUTM1</i> fusion identifies a new subtype of high-grade spindle cell sarcoma
2018 · Molecular Case Studies · 52 citations
https://doi.org/10.1101/mcs.a003194
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor
2020 · Journal of Clinical Investigation · 51 citations
https://doi.org/10.1172/jci139682
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat